Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ruicai Gu and Ralf Janknecht.
Ruicai Gu
Connection Strength
2.258
Ralf Janknecht
  1. Anti-tumor activity of CDYL2b in prostate cancer. Cancer Lett. 2025 Aug 12; 632:217987.
    View in: PubMed
    Score: 0.988
  2. Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis. Front Oncol. 2023; 13:1295613.
    View in: PubMed
    Score: 0.876
  3. Methylation of the JMJD2B epigenetic regulator differentially affects its ability to coactivate the ETV1 and JUN transcription factors. Int J Biochem Mol Biol. 2023; 14(6):101-115.
    View in: PubMed
    Score: 0.220
  4. Crucial Functions of the JMJD1/KDM3 Epigenetic Regulators in Cancer. Mol Cancer Res. 2021 01; 19(1):3-13.
    View in: PubMed
    Score: 0.173
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.